Ask Sterling

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Companies Sectors Ask Sterling Compare

Favorites

Employee Count

Line chart: Employee Count for BioNTech. 2019-2025. Employees: 1,310 in 2019 to 7,807 in 2025.

Employees

Vaccine Milestones

2008

Launch

Ugur Sahin, Ozlem Tureci, and Christoph Huber found BioNTech in Mainz to apply mRNA to individualized cancer vaccines. Infectious-disease mRNA is a later overlay.

Oct 2019

Milestone

BioNTech IPOs on Nasdaq as BNTX (Oct 2019). The listing predates Comirnaty and funds the oncology platform that 2026 guidance still waits on.

Dec 2020

Regulatory

FDA EUA for Comirnaty with Pfizer. BioNTech still held more than 50% of global COVID share in fall 2025.

Dec 2025

Partnership

BioNTech closes the CureVac tender. mRNA design and LNP manufacturing depth. 2026 guidance still assumes no oncology product revenue.

BioNTech (BNTX) - KPIs | Sterling